Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Orthofix Medical (OFIX) EBITDA Margin (2016 - 2025)

Orthofix Medical's EBITDA Margin history spans 16 years, with the latest figure at 92.71% for Q4 2025.

  • For the quarter ending Q4 2025, EBITDA Margin rose 21796.0% year-over-year to 92.71%, compared with a TTM value of 14.66% through Dec 2025, up 4768.0%, and an annual FY2025 reading of 14.45%, up 3171.0% over the prior year.
  • EBITDA Margin for Q4 2025 was 92.71% at Orthofix Medical, up from 11.22% in the prior quarter.
  • The five-year high for EBITDA Margin was 98.12% in Q4 2021, with the low at 125.24% in Q4 2024.
  • Average EBITDA Margin over 5 years is 0.54%, with a median of 4.03% recorded in 2021.
  • Year-over-year, EBITDA Margin crashed -11446bps in 2024 and then soared 21796bps in 2025.
  • Tracing OFIX's EBITDA Margin over 5 years: stood at 98.12% in 2021, then crashed by -71bps to 28.78% in 2022, then tumbled by -137bps to 10.78% in 2023, then crashed by -1062bps to 125.24% in 2024, then soared by 174bps to 92.71% in 2025.
  • Per Business Quant, the three most recent readings for OFIX's EBITDA Margin are 92.71% (Q4 2025), 11.22% (Q3 2025), and 5.55% (Q2 2025).